{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:31:20Z","timestamp":1790519480908,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.blre.2015.08.002","type":"journal-article","created":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T18:46:01Z","timestamp":1439923561000},"page":"73-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?"],"prefix":"10.1016","volume":"30","author":[{"given":"Javeed","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hina","family":"Naushad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfeng","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Bouska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2015.08.002_bb0005","series-title":"Atlas of tumour pathlogy","article-title":"Tumors of the hematopoietic system","author":"Rappaport","year":"1966"},{"issue":"4 Suppl.","key":"10.1016\/j.blre.2015.08.002_bb0010","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C","article-title":"Immunologic characterization of human malignant lymphomas","volume":"34","author":"Lukes","year":"1974","journal-title":"Cancer"},{"issue":"8580","key":"10.1016\/j.blre.2015.08.002_bb0015","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(88)90367-4","article-title":"Updated Kiel classification for lymphomas","volume":"1","author":"Stansfeld","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2015.08.002_bb0020","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2","article-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage","volume":"49","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.blre.2015.08.002_bb0025","article-title":"WHO Classification: Pathology and Genetics of tumors of Haematopoietic and Lymphoid Tissues","volume":"4","author":"Swerdlow","year":"2008"},{"issue":"6","key":"10.1016\/j.blre.2015.08.002_bb0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2796.1998.00343.x","article-title":"The genetic analysis of cancer","volume":"243","author":"Pearson","year":"1998","journal-title":"J Intern Med"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0035","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood.V88.7.2410.bloodjournal8872410","article-title":"Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR\/ABL with C3\/A2 junction)","volume":"88","author":"Pane","year":"1996","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.blre.2015.08.002_bb0040","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"N Engl J Med"},{"issue":"4678","key":"10.1016\/j.blre.2015.08.002_bb0045","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"issue":"2-3","key":"10.1016\/j.blre.2015.08.002_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1383-5742(00)00006-5","article-title":"Recurrent chromosome aberrations in cancer","volume":"462","author":"Mitelman","year":"2000","journal-title":"Mutat Res"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0055","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2008-02-130435","article-title":"Whole genome scanning as a cytogenetic tool in hematologic malignancies","volume":"112","author":"Maciejewski","year":"2008","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0060","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng1307","article-title":"A tiling resolution DNA microarray with complete coverage of the human genome","volume":"36","author":"Ishkanian","year":"2004","journal-title":"Nat Genet"},{"issue":"36","key":"10.1016\/j.blre.2015.08.002_bb0065","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.blre.2015.08.002_bb0070","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nbt1486","article-title":"Next-generation DNA sequencing","volume":"26","author":"Shendure","year":"2008","journal-title":"Nat Biotechnol"},{"issue":"R2","key":"10.1016\/j.blre.2015.08.002_bb0075","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1093\/hmg\/ddp396","article-title":"Cancer genome sequencing: a review","volume":"18","author":"Mardis","year":"2009","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.889","article-title":"Towards a novel classification of human malignancies based on gene expression patterns","volume":"195","author":"Alizadeh","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.blre.2015.08.002_bb0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1101\/sqb.1999.64.71","article-title":"The lymphochip: a specialized cDNA microarray for the genomic-scale analysis of gene expression in normal and malignant lymphocytes","volume":"64","author":"Alizadeh","year":"1999","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.180.1.3","article-title":"G.O.D'.s Holy Grail: discovery of the RAG proteins","volume":"180","author":"Brandt","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0095","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0092-8674(04)00301-0","article-title":"RAG proteins shepherd double-strand breaks to a specific pathway, suppressing error-prone repair, but RAG nicking initiates homologous recombination","volume":"117","author":"Lee","year":"2004","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.molcel.2009.03.009","article-title":"Roles for NBS1 in alternative nonhomologous end-joining of V(D)J recombination intermediates","volume":"34","author":"Deriano","year":"2009","journal-title":"Mol Cell"},{"key":"10.1016\/j.blre.2015.08.002_bb0105","doi-asserted-by":"crossref","unstructured":"Tsai AG, Lieber MR. Mechanisms of chromosomal rearrangement in the human genome. BMC Genomics, 11 Suppl. 1: S1.","DOI":"10.1186\/1471-2164-11-S1-S1"},{"key":"10.1016\/j.blre.2015.08.002_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.immunol.26.021607.090236","article-title":"The biochemistry of somatic hypermutation","volume":"26","author":"Peled","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"22","key":"10.1016\/j.blre.2015.08.002_bb0115","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1158\/0008-5472.CAN-09-1110","article-title":"Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation","volume":"69","author":"Cattoretti","year":"2009","journal-title":"Cancer Res"},{"issue":"6844","key":"10.1016\/j.blre.2015.08.002_bb0120","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"issue":"6769","key":"10.1016\/j.blre.2015.08.002_bb0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.blre.2015.08.002_bb0130","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0135","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","article-title":"The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma","volume":"3","author":"Rosenwald","year":"2003","journal-title":"Cancer Cell"},{"issue":"21","key":"10.1016\/j.blre.2015.08.002_bb0140","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa041869","article-title":"Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells","volume":"351","author":"Dave","year":"2004","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.blre.2015.08.002_bb0145","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0150","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2003-06-2160","article-title":"Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis","volume":"103","author":"Thieblemont","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.08.002_bb0155","series-title":"WHO Classification: pathology and genetics of tumors of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"22","key":"10.1016\/j.blre.2015.08.002_bb0160","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.blre.2015.08.002_bb0165","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2015.08.002_bb0170","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0002-9440(10)63284-1","article-title":"BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma","volume":"165","author":"Iqbal","year":"2004","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.blre.2015.08.002_bb0180","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","article-title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma","volume":"21","author":"Iqbal","year":"2007","journal-title":"Leukemia"},{"issue":"20","key":"10.1016\/j.blre.2015.08.002_bb0185","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1182\/blood-2010-05-285320","article-title":"DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma","volume":"116","author":"Shaknovich","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.blre.2015.08.002_bb0190","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2013-07-509885","article-title":"Variability in DNA methylation defines novel epigenetic subgroups of DLBCL associated with different clinical outcomes","volume":"123","author":"Chambwe","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0195","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2014-04-566778","article-title":"Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma","volume":"125","author":"Iqbal","year":"2015","journal-title":"Blood"},{"issue":"7043","key":"10.1016\/j.blre.2015.08.002_bb0200","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.blre.2015.08.002_bb0205","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0210","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0215","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2004-06-2298","article-title":"Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment","volume":"105","author":"Glas","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0220","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.1103","article-title":"Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)","volume":"30","author":"Horsman","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.blre.2015.08.002_bb0225","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/gcc.20780","article-title":"High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy-neutral loss of heterozygosity and copy number alterations that target single genes","volume":"49","author":"Cheung","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"issue":"16","key":"10.1016\/j.blre.2015.08.002_bb0230","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-07-0456","article-title":"Comprehensive analysis of copy number and allele status identifies multiple chromosome defects underlying follicular lymphoma pathogenesis","volume":"13","author":"Ross","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0235","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/gcc.10314","article-title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","volume":"39","author":"Hoglund","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"11","key":"10.1016\/j.blre.2015.08.002_bb0240","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","article-title":"Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma","volume":"123","author":"Bouska","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0245","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","article-title":"MYC rearrangements in histologically progressed follicular lymphomas","volume":"80","author":"Yano","year":"1992","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0250","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","article-title":"p53 mutation is associated with progression in follicular lymphomas","volume":"82","author":"Sander","year":"1993","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0255","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","article-title":"BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma","volume":"102","author":"Akasaka","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2015.08.002_bb0260","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1182\/blood.V91.8.2977.2977_2977_2984","article-title":"p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas","volume":"91","author":"Pinyol","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0265","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","article-title":"Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma","volume":"91","author":"Elenitoba-Johnson","year":"1998","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2015.08.002_bb0270","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","article-title":"Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations","volume":"101","author":"Martinez-Climent","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0275","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3324\/haematol.2011.048132","article-title":"MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response","volume":"97","author":"Wang","year":"2012","journal-title":"Haematologica"},{"issue":"20","key":"10.1016\/j.blre.2015.08.002_bb0280","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1182\/blood-2011-06-361972","article-title":"MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype","volume":"118","author":"Leich","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2015.08.002_bb0285","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/leu.2009.114","article-title":"Array-based DNA methylation profiling in follicular lymphoma","volume":"23","author":"O'Riain","year":"2009","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.blre.2015.08.002_bb0290","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0295","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0300","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.3324\/haematol.2010.026831","article-title":"Detection of genomic aberrations in molecularly defined Burkitt's lymphoma by array-based, high resolution, single nucleotide polymorphism analysis","volume":"95","author":"Scholtysik","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08883.x","article-title":"Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expression","volume":"155","author":"Schiffman","year":"2011","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.blre.2015.08.002_bb0310","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.13071","article-title":"Chromosomal alterations detected by comparative genomic hybridization in subgroups of gene expression-defined Burkitt's lymphoma","volume":"93","author":"Salaverria","year":"2008","journal-title":"Haematologica"},{"issue":"13","key":"10.1016\/j.blre.2015.08.002_bb0315","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2015.08.002_bb0320","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0325","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.blre.2015.08.002_bb0330","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2006.08.4251","article-title":"Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression-Based Proliferation Signature","author":"Salaverria","year":"2007","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0335","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1002\/ijc.28321","article-title":"Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features","volume":"133","author":"Enjuanes","year":"2013","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0340","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood-2009-12-257485","article-title":"Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma","volume":"116","author":"Leshchenko","year":"2010","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.blre.2015.08.002_bb0345","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1182\/blood-2011-07-370122","article-title":"Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis","volume":"119","author":"Iqbal","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0350","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1182\/blood-2011-02-339556","article-title":"Nodal marginal zone lymphoma: gene expression and miRNA profiling identify diagnostic markers and potential therapeutic targets","volume":"119","author":"Arribas","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2015.08.002_bb0355","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","article-title":"Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0360","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","article-title":"Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association","volume":"79","author":"Fan","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0365","first-page":"60","article-title":"Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas","volume":"63","author":"Kobayashi","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0370","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/gcc.10298","article-title":"Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization","volume":"39","author":"Karnan","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"97","key":"10.1016\/j.blre.2015.08.002_bb0375","first-page":"51","article-title":"Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy","volume":"18","author":"Jardin","year":"2014","journal-title":"Discov Med"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0380","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.humpath.2012.10.026","article-title":"MYD88 expression and L265P mutation in diffuse large B-cell lymphoma","volume":"44","author":"Choi","year":"2013","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.blre.2015.08.002_bb0385","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3109\/10428194.2014.941836","article-title":"Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era","volume":"56","author":"Bohers","year":"2015","journal-title":"Leuk Lymphoma"},{"issue":"7360","key":"10.1016\/j.blre.2015.08.002_bb0390","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"49","key":"10.1016\/j.blre.2015.08.002_bb0395","doi-asserted-by":"crossref","first-page":"20980","DOI":"10.1073\/pnas.1012525107","article-title":"Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas","volume":"107","author":"Sneeringer","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0400","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.blre.2015.08.002_bb0405","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1182\/blood-2013-01-479865","article-title":"Analysis of FOXO1 mutations in diffuse large B-cell lymphoma","volume":"121","author":"Trinh","year":"2013","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0410","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2014","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.blre.2015.08.002_bb0415","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","article-title":"Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma","volume":"121","author":"Green","year":"2013","journal-title":"Blood"},{"issue":"45","key":"10.1016\/j.blre.2015.08.002_bb0420","doi-asserted-by":"crossref","first-page":"18250","DOI":"10.1073\/pnas.1314608110","article-title":"Landscape of somatic mutations and clonal evolution in mantle cell lymphoma","volume":"110","author":"Bea","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.blre.2015.08.002_bb0425","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0430","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat Genet"},{"issue":"7418","key":"10.1016\/j.blre.2015.08.002_bb0435","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.blre.2015.08.002_bb0440","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1186\/1471-2164-13-692","article-title":"Exome-assistant: a rapid and easy detection of disease-related genes and genetic variations from exome sequencing","volume":"13","author":"Liu","year":"2012","journal-title":"BMC Genomics"},{"key":"10.1016\/j.blre.2015.08.002_bb0445","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0065-2776(05)87005-1","article-title":"The biology of human lymphoid malignancies revealed by gene expression profiling","volume":"87","author":"Staudt","year":"2005","journal-title":"Adv Immunol"},{"key":"10.1016\/j.blre.2015.08.002_bb0450","first-page":"69","article-title":"Role of rel family genes in normal and malignant lymphoid cell growth","volume":"15","author":"Gilmore","year":"1992","journal-title":"Cancer Surv"},{"issue":"7247","key":"10.1016\/j.blre.2015.08.002_bb0455","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"47","key":"10.1016\/j.blre.2015.08.002_bb0460","doi-asserted-by":"crossref","first-page":"19946","DOI":"10.1073\/pnas.0907511106","article-title":"Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma","volume":"106","author":"Hailfinger","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.blre.2015.08.002_bb0465","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1182\/blood-2009-01-199679","article-title":"Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma","volume":"113","author":"Dunleavy","year":"2009","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0470","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood-2007-09-111948","article-title":"Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma","volume":"111","author":"Lam","year":"2008","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.blre.2015.08.002_bb0475","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/ng1860","article-title":"JAK signaling globally counteracts heterochromatic gene silencing","volume":"38","author":"Shi","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.blre.2015.08.002_bb0480","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1034\/j.1600-065X.2003.00020.x","article-title":"Regulation of cytokine receptor signaling by SOCS1","volume":"192","author":"Ilangumaran","year":"2003","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.blre.2015.08.002_bb0485","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2015.08.002_bb0490","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.blre.2015.08.002_bb0495","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/sj.leu.2403741","article-title":"Homozygous deletion of SOCS1 in primary mediastinal B-cell lymphoma detected by CGH to BAC microarrays","volume":"19","author":"Mestre","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.blre.2015.08.002_bb0500","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/leu.2008.18","article-title":"DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status","volume":"22","author":"Pike","year":"2008","journal-title":"Leukemia"},{"issue":"7277","key":"10.1016\/j.blre.2015.08.002_bb0505","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.blre.2015.08.002_bb0510","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0515","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri2217","article-title":"Germinal centres: role in B-cell physiology and malignancy","volume":"8","author":"Klein","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"33","key":"10.1016\/j.blre.2015.08.002_bb0520","doi-asserted-by":"crossref","first-page":"22565","DOI":"10.1074\/jbc.M803490200","article-title":"BCL6-mediated attenuation of DNA damage sensing triggers growth arrest and senescence through a p53-dependent pathway in a cell context-dependent manner","volume":"283","author":"Ranuncolo","year":"2008","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.blre.2015.08.002_bb0525","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1182\/blood-2009-06-227017","article-title":"Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells","volume":"115","author":"Basso","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0530","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/nm.2059","article-title":"A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomas","volume":"15","author":"Cerchietti","year":"2009","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.blre.2015.08.002_bb0535","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1134","article-title":"Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells","volume":"10","author":"Polo","year":"2004","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.blre.2015.08.002_bb0540","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2008-01-129783","article-title":"Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study","volume":"112","author":"Young","year":"2008","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.blre.2015.08.002_bb0545","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.1182\/blood-2007-02-072082","article-title":"Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphoma","volume":"110","author":"Young","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0550","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/emboj\/18.1.22","article-title":"Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53","volume":"18","author":"Honda","year":"1999","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2141.2009.07739.x","article-title":"The significance of TP53 in lymphoid malignancies: mutation prevalence, regulation, prognostic impact and potential as a therapeutic target","volume":"146","author":"Cheung","year":"2009","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0560","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1182\/blood-2006-11-059881","article-title":"Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells","volume":"111","author":"Flavell","year":"2008","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.blre.2015.08.002_bb0565","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1158\/1078-0432.CCR-11-0267","article-title":"BCL2 predicts survival in germinal center B-cell-like diffuse large B-cell lymphoma treated with CHOP-like therapy and rituximab","volume":"17","author":"Iqbal","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"11 Pt 1","key":"10.1016\/j.blre.2015.08.002_bb0570","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1158\/1078-0432.CCR-06-0076","article-title":"FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes","volume":"12","author":"Takahashi","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"39","key":"10.1016\/j.blre.2015.08.002_bb0575","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0580","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2004-12-4792","article-title":"Stem cell factor promotes mast cell survival via inactivation of FOXO3a-mediated transcriptional induction and MEK-regulated phosphorylation of the proapoptotic protein Bim","volume":"106","author":"Moller","year":"2005","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.blre.2015.08.002_bb0585","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1182\/blood-2012-04-424630","article-title":"Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells","volume":"120","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0590","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2005-04-1510","article-title":"Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions","volume":"107","author":"Rimsza","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0595","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","article-title":"Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival","volume":"108","author":"Roberts","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0600","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/labinvest.3700697","article-title":"Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy","volume":"88","author":"Gratzinger","year":"2008","journal-title":"Lab Invest"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0605","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.imlet.2007.11.012","article-title":"Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer","volume":"116","author":"Gross","year":"2008","journal-title":"Immunol Lett"},{"issue":"45","key":"10.1016\/j.blre.2015.08.002_bb0610","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth","volume":"27","author":"Whiteside","year":"2008","journal-title":"Oncogene"},{"issue":"Suppl. 14","key":"10.1016\/j.blre.2015.08.002_bb0615","first-page":"S3","article-title":"Cellular and molecular bases of B-cell clonal expansions","volume":"14","author":"Dolcetti","year":"1996","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.blre.2015.08.002_bb0620","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1182\/blood.V89.3.919","article-title":"Maintenance of human germinal center B cells in vitro","volume":"89","author":"Pound","year":"1997","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2015.08.002_bb0625","doi-asserted-by":"crossref","first-page":"e1464","DOI":"10.1371\/journal.pone.0001464","article-title":"Conditional immortalization of human B cells by CD40 ligation","volume":"3","author":"Wiesner","year":"2008","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.blre.2015.08.002_bb0630","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1093\/annonc\/mdt366","article-title":"Long-term follow-up of lenalidomide in relapsed\/refractory mantle cell lymphoma: subset analysis of the NHL-003 study","volume":"24","author":"Zinzani","year":"2013","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.blre.2015.08.002_bb0635","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1517\/17460441.2015.1045295","article-title":"The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma","volume":"10","author":"Smolewski","year":"2015","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.blre.2015.08.002_bb0640","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/asheducation-2011.1.498","article-title":"Relapsed\/refractory diffuse large B-cell lymphoma","volume":"2011","author":"Friedberg","year":"2011","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"10","key":"10.1016\/j.blre.2015.08.002_bb0645","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2003-11-3911","article-title":"Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma","volume":"103","author":"Kewalramani","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0650","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.seminhematol.2015.01.007","article-title":"Novel targeted therapies in diffuse large B-cell lymphoma","volume":"52","author":"Mehta-Shah","year":"2015","journal-title":"Semin Hematol"},{"issue":"9","key":"10.1016\/j.blre.2015.08.002_bb0655","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(14)70327-4","article-title":"A treatment for activated B-cell-like DLBCL?","volume":"15","author":"Zinzani","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.blre.2015.08.002_bb0660","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/annonc\/mdv019","article-title":"Genetic lesions in diffuse large B-cell lymphomas","volume":"26","author":"Testoni","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.blre.2015.08.002_bb0665","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s40265-014-0178-8","article-title":"Ibrutinib: first global approval","volume":"74","author":"Cameron","year":"2014","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.blre.2015.08.002_bb0670","first-page":"299","article-title":"Novel biologic agents for non-Hodgkin lymphoma and chronic lymphocytic leukemia-part 2: adoptive cellular immunotherapy, small-molecule inhibitors, and immunomodulation","volume":"29","author":"Siddiqi","year":"2015","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.blre.2015.08.002_bb0675","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29502","article-title":"A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study","author":"Fenske","year":"2015","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.blre.2015.08.002_bb0680","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1200\/JCO.2012.46.9718","article-title":"Obinutuzumab (GA101) in patients with relapsed\/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study","volume":"31","author":"Salles","year":"2013","journal-title":"J Clin Oncol"},{"issue":"29","key":"10.1016\/j.blre.2015.08.002_bb0685","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.1200\/JCO.2013.49.2835","article-title":"Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study","volume":"31","author":"Goy","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X15000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T16:15:23Z","timestamp":1718036123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X15000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":137,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0268960X15000636"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2015.08.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2015.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}